| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b6fe2dc70267b2d0d61c10d8add8713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d8ad37cda3d6c42dbff3631a75ba62e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dbad7a91ea267d5b4eb11dcf420b43 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-869 |
| filingDate |
2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6577eef3de4ac07d7f7f46e13967e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98898be77107ae5c4087e19cf26751db |
| publicationDate |
2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005049845-A2 |
| titleOfInvention |
Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| abstract |
An herpes simplex virus wherein the herpes simplex virus genome comprises nucleic acid encoding a nitroreductase (NTR) is disclosed. Disclosed herpes simplex viruses are indicated to be useful in the treatment of cancer which may involve gene directed enzyme prodrug therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2593796-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007026146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018115458-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008099189-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020109389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008099189-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2662117-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7897146-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013167909-A1 |
| priorityDate |
2003-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |